在质瘤中EMR2受体功能的研究进展及其作为治疗点的潜在应用
Iuliana Mihaela Buzatu1, Alexandra Costachi2, Anca Oana Docea3
1Doctoral School, University of Medicine and Pharmacy of Craiova, Romania.
Current health sciences journal
|March 27, 2025
概括
皮表皮生长因子模块含有粘素样受体2 (EMR2) 与质瘤的攻击性和患者的生存率低下有关. 针对EMR2可能为脑瘤提供新的治疗策略.
科学领域:
- 神经瘤学神经瘤学
- 分子生物学分子生物学
- 蜂信号传输是如何进行的
背景情况:
- 质瘤是最常见的原发性脑癌.
- 粘附G蛋白结合受体 (aGPCRs),包括EMR2,与癌症进展有关.
- 关于EMR2在质瘤攻击性,存活率和瘤等级方面的作用需要进行调查.
研究的目的:
- 审查EMR2在细胞机制和病理方面的参与,特别是质瘤.
- 总结关于EMR2在脑瘤生物学和临床演变中的作用的当前知识.
主要方法:
- 在PubMed Central,Google Scholar和Scopus数据库中进行系统的文献搜索.
- 使用的关键词:"EMR2"和"结质瘤".
- 录取标准:英语,相关研究设计;排除标准:重复,无关研究. 包括38项研究.
主要成果:
- EMR2在各种质瘤组织学等级中表达.
- 升调EMR2与PI3K-Akt通路有关,促进瘤的侵入性.
- 过度表达EMR2与间酶体质母细胞瘤相关,侵袭性增加,生存率低下.
结论:
- EMR2在质瘤的进展和患者的治疗结果中起着重要作用.
- 重要的是EMR2对中性粒细胞功能 (ROS,脱粒) 的调节.
- 通过基因下调或抗体疗法向EMR2,为质瘤提供了潜在的治疗途径.
更多相关视频
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.6K
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
1.5K
相关概念视频
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Enzyme-linked Receptors
76.7K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
76.7K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
